Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFER-AF: Catheter Ablation vs Usual Care in AF Patients With Intracranial Hemorrhage
NCT07316270Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- May 2026
- Primary completion
- Jan 2030
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) and intracranial hemorrhage (ICH) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Composite of All-Cause Mortality, All-Cause Stroke, and Systemic Embolism at 48 months. Started May 2026; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)intracranial hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07316270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07316270.